Allergic and hypersensitivity condition in the International Patients' Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11.
Allergy
Anaphylaxis
Classification
Coding
Epidemiology
Hypersensitivity
International Classification of Diseases
International Patients Summary
World Health Organization
Journal
The World Allergy Organization journal
ISSN: 1939-4551
Titre abrégé: World Allergy Organ J
Pays: United States
ID NLM: 101481283
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
received:
23
01
2024
revised:
17
05
2024
accepted:
24
05
2024
medline:
10
9
2024
pubmed:
10
9
2024
entrez:
10
9
2024
Statut:
epublish
Résumé
In 2010, the United States Human and Health Services (US HHS) and the European Union's (EU) Directorate General for Communications Networks, Content and Technology signed a memorandum of understanding to stimulate cooperation surrounding health-related information communications technology. The key project that emerged from this agreement is the
Identifiants
pubmed: 39253619
doi: 10.1016/j.waojou.2024.100921
pii: S1939-4551(24)00052-8
pmc: PMC11381440
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100921Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they do not have any conflict of interests related to the contents of this article. PI and consultant for: Novartis, Genentech, Sanofi Regeneron, Astra Zeneca/Amgen, GSK, Allakos, Escient/Incyte, Celldex, Areteia, Takeda/Shire, CSL Behring, Biocryst, Pharming, Kalvista, Ionis, Intellia, Biomarin, Astria, Jaspar.